1 mg tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Tirzepatide Flex-Dose 1 mL Injectable

Spacing doses strategically and taking inositol with meals typically minimizes any discomfort during the first treatment weeks

Ozempic Singapore: A New Contender in Weight Loss and Blood Sugar Control Ozempic (semaglutide injection) is a glucagon-like peptide-1 (GLP-1) receptor agonist that has been shown to be effective in reducing body weight and improving blood sugar control

George JN, Morton JM, Liles NW, Nester CM

Key variants in genes like MC4R (rs17782313) influence how efficiently your body uses GLP-1 receptor stimulation

Some states have covered GLP-1 therapy for obesity, while others have narrowed or ended coverage because of cost

Knowing this ahead of time prevents emotional reactions that derail treatment